Mutation Vif-22H, which allows HIV-1 to use the APOBEC3G hypermutation to develop resistance, could appear more quickly in certain non-B variants

G Yebra; A Holguín

doi:10.1093/jac/dkr012

Mutation Vif-22H, which allows HIV-1 to use the APOBEC3G hypermutation to develop resistance, could appear more quickly in certain non-B variants

G Yebra, A Holguín

Royal (Dick) School of Veterinary Studies

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	941-942
Number of pages	2
Journal	Journal of Antimicrobial Chemotherapy
Volume	66
Issue number	4
DOIs	https://doi.org/10.1093/jac/dkr012
Publication status	Published - Apr 2011

Keywords / Materials (for Non-textual outputs)

APOBEC-3G Deaminase
Adaptation, Biological
Cytidine Deaminase
Drug Resistance, Viral
Genotype
HIV-1
Humans
Mutation, Missense
Recombination, Genetic
Virulence Factors
vif Gene Products, Human Immunodeficiency Virus
Letter
Research Support, Non-U.S. Gov't

Access to Document

10.1093/jac/dkr012

Cite this

@article{f6f4c7adf34045869623cc029a5e8fbb,

title = "Mutation Vif-22H, which allows HIV-1 to use the APOBEC3G hypermutation to develop resistance, could appear more quickly in certain non-B variants",

keywords = "APOBEC-3G Deaminase, Adaptation, Biological, Cytidine Deaminase, Drug Resistance, Viral, Genotype, HIV-1, Humans, Mutation, Missense, Recombination, Genetic, Virulence Factors, vif Gene Products, Human Immunodeficiency Virus, Letter, Research Support, Non-U.S. Gov't",

author = "G Yebra and A Holgu{\'i}n",

year = "2011",

month = apr,

doi = "10.1093/jac/dkr012",

language = "English",

volume = "66",

pages = "941--942",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Mutation Vif-22H, which allows HIV-1 to use the APOBEC3G hypermutation to develop resistance, could appear more quickly in certain non-B variants

AU - Yebra, G

AU - Holguín, A

PY - 2011/4

Y1 - 2011/4

KW - APOBEC-3G Deaminase

KW - Adaptation, Biological

KW - Cytidine Deaminase

KW - Drug Resistance, Viral

KW - Genotype

KW - HIV-1

KW - Humans

KW - Mutation, Missense

KW - Recombination, Genetic

KW - Virulence Factors

KW - vif Gene Products, Human Immunodeficiency Virus

KW - Letter

KW - Research Support, Non-U.S. Gov't

U2 - 10.1093/jac/dkr012

DO - 10.1093/jac/dkr012

M3 - Article

C2 - 21393191

SN - 0305-7453

VL - 66

SP - 941

EP - 942

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 4

ER -